226 related articles for article (PubMed ID: 24223894)
1. C-Met as a prognostic marker in gastric cancer: a systematic review and meta-analysis.
Yu S; Yu Y; Zhao N; Cui J; Li W; Liu T
PLoS One; 2013; 8(11):e79137. PubMed ID: 24223894
[TBL] [Abstract][Full Text] [Related]
2. High c-Met expression is a negative prognostic marker for colorectal cancer: a meta-analysis.
Gao H; Guan M; Sun Z; Bai C
Tumour Biol; 2015 Feb; 36(2):515-20. PubMed ID: 25636446
[TBL] [Abstract][Full Text] [Related]
3. C-Met as a potential novel prognostic marker in squamous cell carcinoma and adenocarcinoma of esophagus: evidence from a meta-analysis.
Ren JL; Wu HF; Wang WJ; Hu GM; Gu B; Zhang M; Wang YX
Panminerva Med; 2017 Mar; 59(1):97-106. PubMed ID: 27636117
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.
Fuse N; Kuboki Y; Kuwata T; Nishina T; Kadowaki S; Shinozaki E; Machida N; Yuki S; Ooki A; Kajiura S; Kimura T; Yamanaka T; Shitara K; Nagatsuma AK; Yoshino T; Ochiai A; Ohtsu A
Gastric Cancer; 2016 Jan; 19(1):183-91. PubMed ID: 25682441
[TBL] [Abstract][Full Text] [Related]
5. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.
Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y
Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of MET amplification and expression in gastric cancer: a systematic review with meta-analysis.
Peng Z; Zhu Y; Wang Q; Gao J; Li Y; Li Y; Ge S; Shen L
PLoS One; 2014; 9(1):e84502. PubMed ID: 24416238
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of c-Met in colorectal cancer: a meta-analysis.
Liu Y; Yu XF; Zou J; Luo ZH
World J Gastroenterol; 2015 Mar; 21(12):3706-10. PubMed ID: 25834339
[TBL] [Abstract][Full Text] [Related]
8. Amplification and expression of c-MET correlate with poor prognosis of patients with gastric cancer and upregulate the expression of PDL1.
Yang Y; Wang C; Dai C; Liu X; Li W; Huang M; Zhao X; Ji D; Li J; Guo W
Acta Biochim Biophys Sin (Shanghai); 2021 Apr; 53(5):547-557. PubMed ID: 33693450
[TBL] [Abstract][Full Text] [Related]
9. Volumetric parameters on
Liu G; Hu Y; Cheng X; Wang Y; Gu Y; Liu T; Shi H
BMC Cancer; 2019 Aug; 19(1):790. PubMed ID: 31395059
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of survivin in patients with gastric cancer: a systematic review with meta-analysis.
Liu JL; Gao W; Kang QM; Zhang XJ; Yang SG
PLoS One; 2013; 8(8):e71930. PubMed ID: 23936532
[TBL] [Abstract][Full Text] [Related]
11. MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma.
Catenacci DV; Ang A; Liao WL; Shen J; O'Day E; Loberg RD; Cecchi F; Hembrough T; Ruzzo A; Graziano F
Cancer; 2017 May; 123(6):1061-1070. PubMed ID: 27926778
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of tumor MET expression among patients with stage IV gastric cancer: a Danish cohort study.
Erichsen R; Kelsh MA; Oliner KS; Nielsen KB; Frøslev T; Lænkholm AV; Vyberg M; Acquavella J; Sørensen HT
Ann Epidemiol; 2016 Jul; 26(7):500-503. PubMed ID: 27318530
[TBL] [Abstract][Full Text] [Related]
13. MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas.
Jin Y; Sun PL; Kim H; Seo AN; Jheon S; Lee CT; Chung JH
Ann Surg Oncol; 2014 Feb; 21(2):621-8. PubMed ID: 24212721
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of Mesenchymal-Epithelial Transition in Triple-Negative Breast Cancers.
Gao HF; Yang CQ; Cheng MY; Zhu T; Yang M; Zhang LL; Wang K
Clin Breast Cancer; 2018 Oct; 18(5):e961-e966. PubMed ID: 29880407
[TBL] [Abstract][Full Text] [Related]
15. MET in gastric cancer--discarding a 10% cutoff rule.
Metzger ML; Behrens HM; Böger C; Haag J; Krüger S; Röcken C
Histopathology; 2016 Jan; 68(2):241-53. PubMed ID: 26033401
[TBL] [Abstract][Full Text] [Related]
16. Tumor MET Expression and Gene Amplification in Chinese Patients with Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer.
Peng Z; Li Z; Gao J; Lu M; Gong J; Tang ET; Oliner KS; Hei YJ; Zhou H; Shen L
Mol Cancer Ther; 2015 Nov; 14(11):2634-41. PubMed ID: 26330547
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of MET gene copy number and protein expression in patients with surgically resected non-small cell lung cancer: a meta-analysis of published literatures.
Guo B; Cen H; Tan X; Liu W; Ke Q
PLoS One; 2014; 9(6):e99399. PubMed ID: 24922520
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and clinicopathological value of Gli-1 expression in gastric cancer: A meta-analysis.
Lu L; Wu M; Zhao F; Fu W; Li W; Li X; Liu T
Oncotarget; 2016 Oct; 7(42):69087-69096. PubMed ID: 27634907
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of the c-MET polymorphism on the clinical outcome in locoregional gastric cancer patients.
Sunakawa Y; Wakatsuki T; Yang D; Zhang W; Ning Y; Stintzing S; Stremitzer S; Yamauchi S; Sebio A; El-khoueiry R; Iqbal S; Barzi A; Gerger A; Stotz M; Azuma M; Watanabe M; Koizumi W; Lenz HJ
Pharmacogenet Genomics; 2014 Dec; 24(12):588-96. PubMed ID: 25203738
[TBL] [Abstract][Full Text] [Related]
20. Human epidermal growth factor receptor 2, epidermal growth factor receptor, and c-MET overexpression and survival in biliary tract cancer: A meta-analysis.
Zhou W; Jiang C; Zhan N; Lv X; Fan L; Ninu M
J Cancer Res Ther; 2018; 14(Supplement):S28-S35. PubMed ID: 29578146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
